Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Health Monitor Liechtenstein.
InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones
GlobeNewswire, Inc.
·
March 20, 2025
Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome (ARDS) Achieved 30-patient recruitment milestone in Phase 3 vilobelimab trial in pyoderma gangrenosum (PG)...
Ligand Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire, Inc.
·
February 27, 2025
Robust financial performance driven by full year 2024 royalty revenue growth of 28% Reiterating 2025 financial guidance of $180-$200 million in revenues and adjusted earnings per diluted share1 of $6.00-$6.25 Conference call and webcast at 8:30...
Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates
GlobeNewswire, Inc.
·
March 29, 2025
SHANGHAI, March 28, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization...
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
GlobeNewswire, Inc.
·
April 1, 2025
With this extension, IXCHIQ®, the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU). Saint Herblain (France), April 1, 2025 – Valneva SE...
President Trump Announces Appointments to the Homeland Security Advisory Council
Department of Homeland Security - Washington D.C.
·
June 24, 2025
President Donald J. Trump and Secretary Noem appointed new members to the Homeland Security Advisory Council (HSAC) and announced the date of the council’s first meeting. Formed on March 19, 2002, the HSAC leverages the experience, expertise, and...
Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®
GlobeNewswire, Inc.
·
February 28, 2025
If granted, IXCHIQ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older Saint Herblain (France), February 28, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a...
Dental Prosthetics Market Projected to Reach USD 15.87 Billion, with a Robust 5.72% CAGR Till 2034
EIN Presswire
·
January 14, 2025
Dental Prosthetics Market Insights: Rising demand due to aging population and aesthetic dentistry trends EU, EUROPEAN UNION, SWEDEN, January 14, 2025 /EINPresswire.com/ -- Market Research Future Latest Industry Insights on Dental Prosthetics...
Dental Consumables Market Growth Outlook: USD 30.47 Billion in 2024 to USD 75.02 Billion by 2032 at 12.4% CAGR
EIN Presswire
·
April 9, 2025
Key Companies covered in dental consumables market are Dentsply Sirona, Institut Straumann AG, ZimVie, Inc., Henry Schein, Inc., Cortex, & others. NY, UNITED STATES, April 9, 2025 /EINPresswire.com/ -- The global dental consumables market was...
Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate
GlobeNewswire, Inc.
·
February 19, 2025
BOSTON, Massachusetts, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or the "Company"), a biotechnology company, today announced that it has entered into an exclusive License agreement with CSPC Megalith Biopharmaceutical...
Global Digital Dentistry Market Report: Projected Growth from USD 4.60 Billion in 2024 to USD 9.22 Billion by 2032
EIN Presswire
·
April 1, 2025
Leading companies in the digital dentistry market include 3Shape A/S, Align Technology, Inc., Dentsply Sirona, Envista, Planmeca Oy, AG, and more. NJ, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- The global digital dentistry market size...
OSCE workshop fosters regional dialogue on climate change, human mobility, and security in South-Eastern Europe
Organization for Security and Co-operation in Europe
·
June 17, 2025
On 3 June, the Office of the Co-ordinator of OSCE Economic and Environmental Activities (OCEEA) hosted a regional workshop in Sarajevo, Bosnia and Herzegovina, bringing together over 50 experts, officials, civil society representatives, and...
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
GlobeNewswire, Inc.
·
March 3, 2025
BASEL, Switzerland and VANCOUVER, B.C. and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle (LNP) patent portfolio (a...
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
GlobeNewswire, Inc.
·
March 3, 2025
BASEL, Switzerland and VANCOUVER, British Columbia and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle (LNP) patent portfolio...
Dental Consumables Market Size to Worth USD 75.02 billion by 2032, CAGR of 12.4% during 2025-2032
EIN Presswire
·
March 5, 2025
Discover the latest trends in the global dental consumables market, explore key players like Dentsply Sirona, Straumann, 3M, ZimVie, Osstem Implant, and more. PUNE, MAHARAHTRA, INDIA, March 5, 2025 /EINPresswire.com/ -- The global dental...
Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older
GlobeNewswire, Inc.
·
January 31, 2025
First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old. The virus-like particle (VLP) single-dose chikungunya vaccine is expected to launch in key European markets in the first half of 2025, pending final marketing...
InflaRx Receives European Commission Approval for GOHIBIC® (vilobelimab) for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS)
GlobeNewswire, Inc.
·
January 15, 2025
JENA, Germany, Jan. 15, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the European Commission (EC) has granted...
bonyf R&D presents its two latest innovations at IDS 2025 in Cologne
EIN Presswire
·
March 6, 2025
bonyf R&D presents its two latest oral care innovations at IDS 2025 in Cologne from 25-29 March 2025 at the IDS. Visit bonyf at the IDS in Hall 5.2, Booth 131. bonyf (MLBON:BE6333353298-XMLI) KNOKKE-HEIST, KNOKKE-HEIST, BELGIUM, March 6, 2025...
Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million
GlobeNewswire, Inc.
·
January 30, 2025
Saint Herblain (France), January 30, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32.8 million contract with the United States (U.S.) Department of Defense (DoD) for the...
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers fourth milestone payment for this region to Basilea this year
GlobeNewswire, Inc.
·
October 10, 2024
Allschwil, Switzerland, October 10, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that...
The European Magazine releases its Philanthropy Focus Supplement, featuring Nigel Mansell CBE's dedication to UK Youth
EIN Presswire
·
February 21, 2025
Leads with Nigel Mansell CBE's 25-year commitment to transforming the lives of young people with UK Youth, by raising millions and launching innovative programs LONDON, UNITED KINGDOM, February 21, 2025 /EINPresswire.com/ -- The supplement leads...